POMC and obesity due to melanocortin 4 receptor deficiency: These findings provide a rational basis for the development of previously unidentified classes of drugs aimed at enhancing G12/13 signaling in POMC neurons for the treatment of various metabolic disorders including obesity and type 2 diabetes.